Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1079047
Abstract: VSA-1 is a semisynthetic saponin adjuvant prepared from naturally occurring Momordica saponin and capable of stimulating antigen-specific humoral and cellular immune responses. Its immunostimulating activity in enhancing the immune responses induced by the clinical glycoconjugate… read more here.
Keywords: saponin; saponin adjuvant; vsa; vaccine pcv13 ... See more keywords